Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study

References

• Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013;10:553–562.
   Google Scholar
• European Association for the study of the Liver (EASL). Clinical practice guidelines: Management of hepatitis C virus infection. J Hepatol 2014;60:392–420.
   Google Scholar
• Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: A translational success story. Gut 2015;64:830–841.
   PubMed Web of Science ®Google Scholar
• Jiang JX, Török NJ. Liver injury and the activation of the hepatic myofibroblasts. Curr Pathobiol Rep 2013;1:215–223.
   PubMedGoogle Scholar
• Schuppan D, Pinzani M. Anti-fibrotic therapy: Lost in translation? J Hepatol 2012;56:566–574.
   Google Scholar
• Chen L, Li J, Zhang J, et al. S100A4 promotes liver fibrosis via activation of hepatic stellate cells. J Hepatol 2015;62:156–164.
   PubMed Web of Science ®Google Scholar
• Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TCF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76–99.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner DA. Fibrogenesis of parenchymal organs. Proc Am Thorac Soc 2008;5:338–342.
   PubMedGoogle Scholar
• Friedman SL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125–172
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner DA. Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol 2011;25:305–317.
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Parola M. Liver fibrogenic cells. Best Pract Res Clin Gastroenterol 2011;25:207–217.
   PubMed Web of Science ®Google Scholar
• Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology. Nat Commun 2013;4:2823–2832.
   PubMed Web of Science ®Google Scholar
• Xu J, Min Cong M, Park TJ, et al. Contribution of bone marrow-derived fibrocytes to liver fibrosis. Hepatobiliary Surg Nutr 2015;4:34–47.
   PubMed Web of Science ®Google Scholar
• Bárcena C, Stefanovic M, Tutusaus A, et al. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation. J Hepatol 2015;63:670–678.
   PubMed Web of Science ®Google Scholar
• Lei XF, Fu W, Kaneyama J, et al. Huc-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice. J Hepatol 2016;64:110–117.
   PubMed Web of Science ®Google Scholar
• Miyata E, Masuya M, Yoshida S, et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 2008;111:2427–2435.
   PubMed Web of Science ®Google Scholar
• Goodpaster T, Legesse-Miller A, Hameed MR, et al. An immunohistochemical method for identifying fibroblasts in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 2008;56:347–358.
   PubMed Web of Science ®Google Scholar
• Novo E, Bonzo L, Cannito S, et al. Hepatic myofibroblasts: A heterogeneous population of multifunctional cells in liver fibrogenesis. Int J Biochem Cell Biol 2009;41:2089–2093.
   PubMed Web of Science ®Google Scholar
• Atzori L, Pli G, Perr A. Hepatic stellate cell: A star cell in the liver. Int J Biochem Cell Biol 2009;41:1639–1642.
   Google Scholar
• Venugopal SK, Jiang J, Kim TH, et al. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 2010;298:G101–G106.
   PubMed Web of Science ®Google Scholar
• Yin C, Evason KJ, Asahina K, et al. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest 2013;123:1902–1910.
   Google Scholar
• Nepomnyashchikh GI, Aidagulova SV, Nepomnyashchikh DL, et al. Ultrastructural and immunohistochemical study of hepatic stellate cells over the course of infectious viral fibrosis and cirrhosis of the liver. Bull Exp Biol Med 2006;142:723–728.
   PubMed Web of Science ®Google Scholar
• Mansy SS, ElKafif N, AbdelFatah A, et al. Hepatic stellate cell and fibrogenesis in cases of HCV infection: An ultrastructural insight. Ultrastruct Pathol 2010;34:62–67.
   PubMed Web of Science ®Google Scholar
• Iwaisako K, Taura K, Koyama Y, et al. Strategies to detect Hepatic myofibroblasts in liver cirrhosis of different etiologies. Curr Pathobiol Rep 2014;2:209–215.
   PubMedGoogle Scholar
• Halfon P, Bourlière M, Pénaranda G, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C. Comp Hepatol 2005;4:6–11.
   PubMedGoogle Scholar
• Baranova A, Lal P, Birerdinc A, et al. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol 2011;11:91–106.
   PubMed Web of Science ®Google Scholar
• Singer KH, Scearce RM, Tuck DT, et al. Removal of fibroblasts from human epithelial cell cultures with use of a complement fixing monoclonal antibody reactive with human fibroblasts and monocytes/macrophages. J Invest Dermatol 1989;92:166–170.
   PubMed Web of Science ®Google Scholar
• Botella-López A, Madaria E, Jover R, et al. Reelin is over-expressed in the liver and plasma of bile duct ligated rats and its levels and glycosylation are altered in plasma of humans with cirrhosis. Int J Biochem Cell Biol 2008;40:766–775.
   PubMed Web of Science ®Google Scholar
• Alt E, Yan Y, Gehmert S, et al. Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol Cell 2011;103:197–208.
   PubMed Web of Science ®Google Scholar
• Liu X, Xu J, Brenner DA, et al. Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts. Curr Pathobiol Rep 2013;1:209–214.
   PubMedGoogle Scholar
• Mansy SS, Nosseir MM, Zoheiry MA, et al. Value of reelin for assessing hepatic fibrogenesis in a group of Egyptian HCV infected patients. Clin Chem Lab Med 2014;52:1319–1328.
   PubMed Web of Science ®Google Scholar
• Schurch W, Seemayer TA, Hinz B, Gabbiani G. Myofibroblast. In: Mills SE, (ed.), Histology for pathologists. Philadelphia: Lippincott Williams & Wilkins, 2007, p. 125.
   Google Scholar
• Bedossa P, Bioulac-Sage P, Callard P, et al. The French METAVIR Cooperative Study Group intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15–20.
   PubMed Web of Science ®Google Scholar
• Leroy V, Hilleret MN, Sturm N, et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007;46:775–782.
   PubMed Web of Science ®Google Scholar
• Becker L, Salameh W, Sferruzza A, et al. Validation of Hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol 2009;7:696–701.
   PubMed Web of Science ®Google Scholar
• Ahmad W, Ijaz B, Javed FT, et al. Comparison of four fibrosis indexes in chronic HCV: Development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol 2011;11:44–54.
   PubMed Web of Science ®Google Scholar
• Johnson ID. Practical considerations in the selection and application of fluorescent probes. In: Pawley JB, (ed.), Handbook of biological confocal microscopy, 3rd edn. New York: Plenum Press; 2006; p. 362.
   Google Scholar
• Seki E, Brenner DA. Recent advancement of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat Sci 2015;22:512–518.
   PubMed Web of Science ®Google Scholar
• Iwaisako K, Brenner DA, Kisseleva T. What’s new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol 2012;27:65–68.
   PubMed Web of Science ®Google Scholar
• Shirakami Y, Lee SA, Clugston RD, et al. Hepatic metabolism of retinoids and disease association. Biochim Biophys Acta 2012;1821:124–136.
   PubMed Web of Science ®Google Scholar
• Samama B, Boehm N. Reelin immunoreactivity in lymphatics and liver during development and adult life. Anat Rec A Discov Mol Cell Evol Biol 2005;285:595–599.
   PubMedGoogle Scholar
• Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 2001;166:7556–7562.
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429–438.
   PubMed Web of Science ®Google Scholar
• Scholten D, Reichart D, Paik YH, et al. Migration of fibrocytes in fibrogenic liver injury. Am J Pathol 2011;179:189–198.
   PubMed Web of Science ®Google Scholar
• Akamatsu T, Arai Y, Kosugi I, et al. Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences. Fibrogenesis Tissue Repair 2013;6:15–621.
   PubMedGoogle Scholar
• Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001;21:437–451.
   PubMed Web of Science ®Google Scholar
• Moles A, Tarrats N, Morales A, et al. Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. Am J Pathol 2010;177:1214–1224.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Kim YO. Evolving therapies for liver fibrosis. J Clin Invest 2013;123:1887–1901.
   Google Scholar